🇺🇸 FDA
Patent

US 12427212

Nectin-4 binding miniproteins, conjugates and uses thereof

granted A61KA61K2121/00A61K38/00

Quick answer

US patent 12427212 (Nectin-4 binding miniproteins, conjugates and uses thereof) held by Aktis Oncology, Inc. expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aktis Oncology, Inc.
Grant date
Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K2121/00, A61K38/00, A61K51/088, A61P